世界の間葉系幹細胞市場2021-2028:製品&サービス別、種類別、分離源別(骨髄、臍帯血)、疾患別、用途別、地域別

◆英語タイトル:Mesenchymal Stem Cells Market Size, Share & Trends Analysis Report By Product & Services, By Type, By Source Of Isolation (Bone Marrow, Cord Blood), By Indication, By Application, By Region, And Segment Forecasts, 2021 - 2028
◆商品コード:GV21MY052
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2021年5月18日
◆ページ数:140
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥654,500見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥764,500見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥984,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

グランドビューリサーチ社は、世界の間葉系幹細胞市場規模が2028年までに61億ドルに達すると予測しています。2021年から2028年までに年平均12.6%成長する見通しです。本市場調査資料では、間葉系幹細胞の世界市場について調査し、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、製品&サービス別(製品、サービス)分析、種類別(自家、同種異系)分析、分離源別(骨髄、臍帯血、末梢血、卵管、胎児肝臓)分析、疾患別(骨&軟骨修復、心血管疾患、炎症&免疫疾患、肝疾患、癌)分析、地域別分析、企業情報など、以下の構成でまとめております。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・世界の間葉系幹細胞市場規模:製品&サービス別(製品、サービス)
・世界の間葉系幹細胞市場規模:種類別(自家、同種異系)
・世界の間葉系幹細胞市場規模:分離源別(骨髄、臍帯血、末梢血、卵管、胎児肝臓)
・世界の間葉系幹細胞市場規模:疾患別(骨&軟骨修復、心血管疾患、炎症&免疫疾患、肝疾患、癌)
・世界の間葉系幹細胞市場規模:地域別
・企業情報
【レポートの概要】

Table of Contents

Chapter 1 Methodology And Scope
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates And Forecast Timeline
1.3 Research Methodology
1.4 Information Procurement
1.4.1 Purchased Database
1.4.2 GVR’S Internal Database
1.4.3 Secondary Sources
1.4.4 Primary Research
1.4.5 Details Of Primary Research
1.5 Information or Data Analysis
1.5.1 Data Analysis Models
1.6 Market Formulation & Validation
1.7 Model Details
1.7.1 Commodity Flow Analysis
1.7.1.1 Approach 1: Commodity Flow Approach
1.7.1.2 Approach 2: Country-Wise Market Estimation Using Bottom-Up Approach
1.8 Market: CAGR Calculation
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective 1:
1.11.2 Objective 2:
Chapter 2 Executive Summary
2.1 Competition Milieu
2.2 Segment Outlook
Chapter 3 Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Technology Overview
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Expanding Pipeline And Clinical Studies Of Mesenchymal Stem Cell Based Products
3.3.1.2 Emerging Applications of MSCs
3.3.1.3 Rising Market Competition Among Key Players
3.3.2 Market Restraint Analysis
3.3.2.1 Lack Of Standardized & Regulated Delivery of Stem Cell Therapy
3.3.2.2 Ethical & Safety Concerns Controversies Associated With Human MSC Therapy
3.3.3 Market Opportunity Analysis
3.3.3.1 Use Of Mesenchymal Stem Cells In Regenerative Medicine
3.4 Penetration & Growth Prospect Mapping for Applications, 2020
3.5 Mesenchymal Stem Cells Market-SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
3.6 Industry Analysis – Porter’s
3.7 COVID-19 Impact Analysis
3.8 Major Deals & Strategic Alliances Analysis
3.8.1 Mergers & Acquisitions
3.8.2 Technological Collaborations
3.8.3 Licensing & Partnership
3.8.4 Strategic Divestments
3.9 Public Companies
3.9.1 Competitive Dashboard Analysis
3.9.2 Market Differentiators
3.10 Private Companies
3.10.1 List Of Emerging Players
3.10.2 Funding Outlook
Chapter 4 Mesenchymal Stem Cells (MSCs) Market: Product & Services Business Analysis
4.1 Mesenchymal Stem Cells Market: Product & Services Movement Analysis
4.2 By Workflow
4.2.1 Cell Sourcing And Isolation
4.2.1.1 Mesenchymal Stem Cell Sourcing And Isolation Market Estimates And Forecast, 2017 – 2028 (USD Million)
4.2.2 Culture & Cryopreservation
4.2.2.1 Mesenchymal Stem Cell Culture & Cryopreservation Market Estimates And Forecast, 2017 – 2028 (USD Million)
4.2.3 Differentiation
4.2.3.1 Mesenchymal Stem Cell Differentiation Market Estimates And Forecast, 2017 – 2028 (USD Million)
4.2.4 Characterization
4.2.4.1 Mesenchymal Stem Cell Characterization Market Estimates And Forecast, 2017 – 2028 (USD Million)
4.3 By Product
4.3.1 Cells & Cell Lines
4.3.1.1 Mesenchymal Stem Cells And Cell Lines Market Estimates And Forecast, 2017 – 2028 (USD Million)
4.3.2 Kits, Media & Reagents
4.3.2.1 Mesenchymal Stem Cell Kits, Media & Reagents Market Estimates And Forecast, 2017 – 2028 (USD Million)
4.3.3 Others
4.3.3.1 Others Mesenchymal Stem Cell Products Market Estimates And Forecast, 2017 – 2028 (USD Million)
4.4 Services
4.4.1 Mesenchymal Stem Cell Services Market Estimates And Forecast, 2017 – 2028 (USD Million)
Chapter 5 Mesenchymal Stem Cells (MSCs) Market: Type Business Analysis
5.1 Mesenchymal Stem Cells Market: Type Movement Analysis
5.2 Autologous
5.2.1 Autologous MSCs Market Estimates And Forecast, 2017 – 2028 (USD Million)
5.3 Allogeneic
5.3.1 Allogeneic MSCs Market Estimates And Forecast, 2017 – 2028 (USD Million)
Chapter 6 Mesenchymal Stem Cells (MSCs) Market: Source Of Isolation Business Analysis
6.1 Mesenchymal Stem Cells Market: Source Of Isolation Movement Analysis
6.2 Bone Marrow
6.2.1 Bone Marrow Derived MSCs Estimates And Forecast, 2017 – 2028 (USD Million)
6.3 Cord Blood
6.3.1 Cord Blood Derived MSCs Estimates And Forecast, 2017 – 2028 (USD Million)
6.4 Peripheral Blood
6.4.1 Peripheral Blood Derived MSCs Estimates And Forecast, 2017 – 2028 (USD Million)
6.5 Fallopian Tube
6.5.1 Fallopian Tube Derived MSCs Estimates And Forecast, 2017 – 2028 (USD Million)
6.6 Fetal Liver
6.6.1 Fetal Liver Derived MSCs Estimates And Forecast, 2017 – 2028 (USD Million)
6.7 Lung
6.7.1 Lung Derived MSCs Estimates And Forecast, 2017 – 2028 (USD Million)
6.8 Adipose Tissues
6.8.1 Adipose Tissue Derived MSCs Estimates And Forecast, 2017 – 2028 (USD Million)
Chapter 7 Mesenchymal Stem Cells (MSCs) Market: Indication Business Analysis
7.1 Mesenchymal Stem Cells Market: Indication Movement Analysis
7.2 Bone & Cartilage Repair
7.2.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For Bone & Cartilage Repair, 2017 – 2028 (USD Million)
7.3 Cardiovascular Disease
7.3.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For Cardiovascular Diseases, 2017 – 2028 (USD Million)
7.4 Inflammatory And Immunological Disease
7.4.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For Inflammatory And Immunological Diseases, 2017 – 2028 (USD Million)
7.5 Liver Diseases
7.5.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For Liver Diseases, 2017 – 2028 (USD Million)
7.6 Cancer
7.6.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For Cancer, 2017 – 2028 (USD Million)
7.7 GvHD
7.7.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For GvHD, 2017 – 2028 (USD Million)
7.8 Others
7.8.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For Others, 2017 – 2028 (USD Million)
Chapter 8 Mesenchymal Stem Cells (MSCs) Market: Application Business Analysis
8.1 Mesenchymal Stem Cells Market: Application Movement Analysis
8.2 Disease Modeling
8.2.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For Disease Modeling, 2017 – 2028 (USD Million)
8.3 Drug Development & Discovery
8.3.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For Drug Development & Discovery, 2017 – 2028 (USD Million)
8.4 Stem Cell Banking
8.4.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For Stem Cell Banking, 2017 – 2028 (USD Million)
8.5 Tissue Engineering
8.5.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For Tissue Engineering, 2017 – 2028 (USD Million)
8.6 Toxicology Studies
8.6.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For Toxicology Studies, 2017 – 2028 (USD Million)
8.7 Others
8.7.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For Others, 2017 – 2028 (USD Million)
Chapter 9 Mesenchymal Stem Cells (MSCs) Market: Regional Business Analysis
9.1 Mesenchymal Stem Cells (Mscs) Market: Regional Movement Analysis
9.2 North America
9.2.1 North America Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Product & Services, 2017 – 2028 (USD Million)
9.2.2 North America Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Type, 2017 – 2028 (USD Million)
9.2.3 North America Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Source Of Isolation, 2017 – 2028 (USD Million)
9.2.4 North America Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Indication, 2017 – 2028 (USD Million)
9.2.5 North America Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Application, 2017 – 2028 (USD Million)
9.2.6 U.S.
9.2.6.1 U.S. Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 – 2028 (USD Million)
9.2.7 Canada
9.2.7.1 Canada Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 – 2028 (USD Million)
9.3 Europe
9.3.1 Europe Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Product & Services, 2017 – 2028 (USD Million)
9.3.2 Europe Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Type, 2017 – 2028 (USD Million)
9.3.3 Europe Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Source Of Isolation, 2017 – 2028 (USD Million)
9.3.4 Europe Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Indication, 2017 – 2028 (USD Million)
9.3.5 Europe Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Application, 2017 – 2028 (USD Million)
9.3.6 U.K.
9.3.6.1 U.K. Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 – 2028 (USD Million)
9.3.7 Germany
9.3.7.1 Germany Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 – 2028 (USD Million)
9.3.8 France
9.3.8.1 France Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 – 2028 (USD Million)
9.3.9 Italy
9.3.9.1 Italy Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 – 2028 (USD Million)
9.4 Asia Pacific
9.4.1 Asia Pacific Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Product & Services, 2017 – 2028 (USD Million)
9.4.2 Asia Pacific Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Type, 2017 – 2028 (USD Million)
9.4.3 Asia Pacific Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Source Of Isolation, 2017 – 2028 (USD Million)
9.4.4 Asia Pacific Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Indication, 2017 – 2028 (USD Million)
9.4.5 Asia Pacific Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Application, 2017 – 2028 (USD Million)
9.4.6 China
9.4.6.1 China Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 – 2028 (USD Million)
9.4.7 Japan
9.4.7.1 Japan Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 – 2028 (USD Million)
9.4.8 India
9.4.8.1 India Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 – 2028 (USD Million)
9.4.9 South Korea
9.4.9.1 South Korea Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 – 2028 (USD Million)
9.5 Latin America
9.5.1 Latin America Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Product & Services, 2017 – 2028 (USD Million)
9.5.2 Latin America Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Type, 2017 – 2028 (USD Million)
9.5.3 Latin America Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Source Of Isolation, 2017 – 2028 (USD Million)
9.5.4 Latin America Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Indication, 2017 – 2028 (USD Million)
9.5.5 Latin America Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Application, 2017 – 2028 (USD Million)
9.5.6 Brazil
9.5.6.1 Brazil Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 – 2028 (USD Million)
9.5.7 Mexico
9.5.7.1 Mexico Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 – 2028 (USD Million)
9.6 Middle East & Africa (Mea)
9.6.1 Mea Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Product & Services, 2017 – 2028 (USD Million)
9.6.2 Mea Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Type, 2017 – 2028 (USD Million)
9.6.3 Mea Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Source Of Isolation, 2017 – 2028 (USD Million)
9.6.4 Mea Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Indication, 2017 – 2028 (USD Million)
9.6.5 Mea Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Application, 2017 – 2028 (USD Million)
9.6.6 South Africa
9.6.6.1 South Africa Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 – 2028 (USD Million)
9.6.7 Saudi Arabia
9.6.7.1 Saudi Arabia Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 – 2028 (USD Million)
Chapter 10 Company Profile
10.1 Strategy Framework
10.2 Market Participation Categorization
10.3 Company Profiles
10.3.1 THERMO FISHER SCIENTIFIC
10.3.1.1 Company Overview
10.3.1.2 Financial Performance
10.3.1.3 Product Benchmarking
10.3.1.4 Strategic Initiatives
10.3.2 CELL APPLICATIONS, INC.
10.3.2.1 Company Overview
10.3.2.2 Financial Performance
10.3.2.3 Product Benchmarking
10.3.2.4 Strategic Initiatives
10.3.3 CYAGEN BIOSCIENCES INC.
10.3.3.1 Company Overview
10.3.3.2 Financial Performance
10.3.3.3 Product Benchmarking
10.3.4 AXOL BIOSCIENCES LTD.
10.3.4.1 Company Overview
10.3.4.2 Financial Performance
10.3.4.3 Product Benchmarking
10.3.4.4 Strategic Initiatives
10.3.5 CYTORI THERAPEUTICS INC
10.3.5.1 Company Overview
10.3.5.2 Financial Performance
10.3.5.3 Product Benchmarking
10.3.5.4 Strategic Initiatives
10.3.6 STEMCELL TECHNOLOGIES INC.
10.3.6.1 Company Overview
10.3.6.2 Financial Performance
10.3.6.3 Product Benchmarking
10.3.6.4 Strategic Initiatives
10.3.7 CELPROGEN INC.
10.3.7.1 Company Overview
10.3.7.2 Financial Performance
10.3.7.3 Product Benchmarking
10.3.7.4 Strategic Initiatives
10.3.8 BRAINSTORM CELL THERAPEUTICS INC.
10.3.8.1 Company Overview
10.3.8.2 Financial Performance
10.3.8.3 Product Benchmarking
10.3.8.4 Strategic Initiatives
10.3.9 STEMEDICA CELL TECHNOLOGIES INC.
10.3.9.1 Company Overview
10.3.9.2 Financial Performance
10.3.9.3 Product Benchmarking
10.3.9.4 Strategic Initiatives
10.3.10 MERCK KGAA (MILLIPORESIGMA)
10.3.10.1 Company Overview
10.3.10.2 Financial Performance
10.3.10.3 Product Benchmarking
10.3.10.4 Strategic Initiatives
10.3.11 SMITH+NEPHEW
10.3.11.1 Company Overview
10.3.11.2 Osiris Therapeutics Inc.
10.3.11.3 Financial Performance
10.3.11.4 Product Benchmarking
10.3.11.5 Strategic Initiatives
10.3.12 LONZA AG
10.3.12.1 Company Overview
10.3.12.2 Financial Performance
10.3.12.3 Product Benchmarking
10.3.13 PROMOCELL GMBH
10.3.13.1 Company Overview
10.3.13.2 Financial Performance
10.3.13.3 Product Benchmarking
10.3.13.4 Strategic Initiatives
10.3.14 SCIENCELL RESEARCH LABORATORIES
10.3.14.1 Company Overview
10.3.14.2 Financial Performance
10.3.14.3 Product Benchmarking
10.3.15 AMERICAN TYPE CULTURE COLLECTION
10.3.15.1 Company Overview
10.3.15.2 Financial Performance
10.3.15.3 Product Benchmarking

【レポートの目次】

Table of Contents

Chapter 1 Methodology And Scope
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates And Forecast Timeline
1.3 Research Methodology
1.4 Information Procurement
1.4.1 Purchased Database
1.4.2 GVR’S Internal Database
1.4.3 Secondary Sources
1.4.4 Primary Research
1.4.5 Details Of Primary Research
1.5 Information or Data Analysis
1.5.1 Data Analysis Models
1.6 Market Formulation & Validation
1.7 Model Details
1.7.1 Commodity Flow Analysis
1.7.1.1 Approach 1: Commodity Flow Approach
1.7.1.2 Approach 2: Country-Wise Market Estimation Using Bottom-Up Approach
1.8 Market: CAGR Calculation
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective 1:
1.11.2 Objective 2:
Chapter 2 Executive Summary
2.1 Competition Milieu
2.2 Segment Outlook
Chapter 3 Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Technology Overview
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Expanding Pipeline And Clinical Studies Of Mesenchymal Stem Cell Based Products
3.3.1.2 Emerging Applications of MSCs
3.3.1.3 Rising Market Competition Among Key Players
3.3.2 Market Restraint Analysis
3.3.2.1 Lack Of Standardized & Regulated Delivery of Stem Cell Therapy
3.3.2.2 Ethical & Safety Concerns Controversies Associated With Human MSC Therapy
3.3.3 Market Opportunity Analysis
3.3.3.1 Use Of Mesenchymal Stem Cells In Regenerative Medicine
3.4 Penetration & Growth Prospect Mapping for Applications, 2020
3.5 Mesenchymal Stem Cells Market-SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
3.6 Industry Analysis – Porter’s
3.7 COVID-19 Impact Analysis
3.8 Major Deals & Strategic Alliances Analysis
3.8.1 Mergers & Acquisitions
3.8.2 Technological Collaborations
3.8.3 Licensing & Partnership
3.8.4 Strategic Divestments
3.9 Public Companies
3.9.1 Competitive Dashboard Analysis
3.9.2 Market Differentiators
3.10 Private Companies
3.10.1 List Of Emerging Players
3.10.2 Funding Outlook
Chapter 4 Mesenchymal Stem Cells (MSCs) Market: Product & Services Business Analysis
4.1 Mesenchymal Stem Cells Market: Product & Services Movement Analysis
4.2 By Workflow
4.2.1 Cell Sourcing And Isolation
4.2.1.1 Mesenchymal Stem Cell Sourcing And Isolation Market Estimates And Forecast, 2017 – 2028 (USD Million)
4.2.2 Culture & Cryopreservation
4.2.2.1 Mesenchymal Stem Cell Culture & Cryopreservation Market Estimates And Forecast, 2017 – 2028 (USD Million)
4.2.3 Differentiation
4.2.3.1 Mesenchymal Stem Cell Differentiation Market Estimates And Forecast, 2017 – 2028 (USD Million)
4.2.4 Characterization
4.2.4.1 Mesenchymal Stem Cell Characterization Market Estimates And Forecast, 2017 – 2028 (USD Million)
4.3 By Product
4.3.1 Cells & Cell Lines
4.3.1.1 Mesenchymal Stem Cells And Cell Lines Market Estimates And Forecast, 2017 – 2028 (USD Million)
4.3.2 Kits, Media & Reagents
4.3.2.1 Mesenchymal Stem Cell Kits, Media & Reagents Market Estimates And Forecast, 2017 – 2028 (USD Million)
4.3.3 Others
4.3.3.1 Others Mesenchymal Stem Cell Products Market Estimates And Forecast, 2017 – 2028 (USD Million)
4.4 Services
4.4.1 Mesenchymal Stem Cell Services Market Estimates And Forecast, 2017 – 2028 (USD Million)
Chapter 5 Mesenchymal Stem Cells (MSCs) Market: Type Business Analysis
5.1 Mesenchymal Stem Cells Market: Type Movement Analysis
5.2 Autologous
5.2.1 Autologous MSCs Market Estimates And Forecast, 2017 – 2028 (USD Million)
5.3 Allogeneic
5.3.1 Allogeneic MSCs Market Estimates And Forecast, 2017 – 2028 (USD Million)
Chapter 6 Mesenchymal Stem Cells (MSCs) Market: Source Of Isolation Business Analysis
6.1 Mesenchymal Stem Cells Market: Source Of Isolation Movement Analysis
6.2 Bone Marrow
6.2.1 Bone Marrow Derived MSCs Estimates And Forecast, 2017 – 2028 (USD Million)
6.3 Cord Blood
6.3.1 Cord Blood Derived MSCs Estimates And Forecast, 2017 – 2028 (USD Million)
6.4 Peripheral Blood
6.4.1 Peripheral Blood Derived MSCs Estimates And Forecast, 2017 – 2028 (USD Million)
6.5 Fallopian Tube
6.5.1 Fallopian Tube Derived MSCs Estimates And Forecast, 2017 – 2028 (USD Million)
6.6 Fetal Liver
6.6.1 Fetal Liver Derived MSCs Estimates And Forecast, 2017 – 2028 (USD Million)
6.7 Lung
6.7.1 Lung Derived MSCs Estimates And Forecast, 2017 – 2028 (USD Million)
6.8 Adipose Tissues
6.8.1 Adipose Tissue Derived MSCs Estimates And Forecast, 2017 – 2028 (USD Million)
Chapter 7 Mesenchymal Stem Cells (MSCs) Market: Indication Business Analysis
7.1 Mesenchymal Stem Cells Market: Indication Movement Analysis
7.2 Bone & Cartilage Repair
7.2.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For Bone & Cartilage Repair, 2017 – 2028 (USD Million)
7.3 Cardiovascular Disease
7.3.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For Cardiovascular Diseases, 2017 – 2028 (USD Million)
7.4 Inflammatory And Immunological Disease
7.4.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For Inflammatory And Immunological Diseases, 2017 – 2028 (USD Million)
7.5 Liver Diseases
7.5.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For Liver Diseases, 2017 – 2028 (USD Million)
7.6 Cancer
7.6.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For Cancer, 2017 – 2028 (USD Million)
7.7 GvHD
7.7.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For GvHD, 2017 – 2028 (USD Million)
7.8 Others
7.8.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For Others, 2017 – 2028 (USD Million)
Chapter 8 Mesenchymal Stem Cells (MSCs) Market: Application Business Analysis
8.1 Mesenchymal Stem Cells Market: Application Movement Analysis
8.2 Disease Modeling
8.2.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For Disease Modeling, 2017 – 2028 (USD Million)
8.3 Drug Development & Discovery
8.3.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For Drug Development & Discovery, 2017 – 2028 (USD Million)
8.4 Stem Cell Banking
8.4.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For Stem Cell Banking, 2017 – 2028 (USD Million)
8.5 Tissue Engineering
8.5.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For Tissue Engineering, 2017 – 2028 (USD Million)
8.6 Toxicology Studies
8.6.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For Toxicology Studies, 2017 – 2028 (USD Million)
8.7 Others
8.7.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For Others, 2017 – 2028 (USD Million)
Chapter 9 Mesenchymal Stem Cells (MSCs) Market: Regional Business Analysis
9.1 Mesenchymal Stem Cells (Mscs) Market: Regional Movement Analysis
9.2 North America
9.2.1 North America Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Product & Services, 2017 – 2028 (USD Million)
9.2.2 North America Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Type, 2017 – 2028 (USD Million)
9.2.3 North America Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Source Of Isolation, 2017 – 2028 (USD Million)
9.2.4 North America Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Indication, 2017 – 2028 (USD Million)
9.2.5 North America Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Application, 2017 – 2028 (USD Million)
9.2.6 U.S.
9.2.6.1 U.S. Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 – 2028 (USD Million)
9.2.7 Canada
9.2.7.1 Canada Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 – 2028 (USD Million)
9.3 Europe
9.3.1 Europe Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Product & Services, 2017 – 2028 (USD Million)
9.3.2 Europe Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Type, 2017 – 2028 (USD Million)
9.3.3 Europe Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Source Of Isolation, 2017 – 2028 (USD Million)
9.3.4 Europe Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Indication, 2017 – 2028 (USD Million)
9.3.5 Europe Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Application, 2017 – 2028 (USD Million)
9.3.6 U.K.
9.3.6.1 U.K. Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 – 2028 (USD Million)
9.3.7 Germany
9.3.7.1 Germany Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 – 2028 (USD Million)
9.3.8 France
9.3.8.1 France Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 – 2028 (USD Million)
9.3.9 Italy
9.3.9.1 Italy Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 – 2028 (USD Million)
9.4 Asia Pacific
9.4.1 Asia Pacific Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Product & Services, 2017 – 2028 (USD Million)
9.4.2 Asia Pacific Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Type, 2017 – 2028 (USD Million)
9.4.3 Asia Pacific Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Source Of Isolation, 2017 – 2028 (USD Million)
9.4.4 Asia Pacific Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Indication, 2017 – 2028 (USD Million)
9.4.5 Asia Pacific Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Application, 2017 – 2028 (USD Million)
9.4.6 China
9.4.6.1 China Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 – 2028 (USD Million)
9.4.7 Japan
9.4.7.1 Japan Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 – 2028 (USD Million)
9.4.8 India
9.4.8.1 India Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 – 2028 (USD Million)
9.4.9 South Korea
9.4.9.1 South Korea Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 – 2028 (USD Million)
9.5 Latin America
9.5.1 Latin America Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Product & Services, 2017 – 2028 (USD Million)
9.5.2 Latin America Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Type, 2017 – 2028 (USD Million)
9.5.3 Latin America Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Source Of Isolation, 2017 – 2028 (USD Million)
9.5.4 Latin America Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Indication, 2017 – 2028 (USD Million)
9.5.5 Latin America Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Application, 2017 – 2028 (USD Million)
9.5.6 Brazil
9.5.6.1 Brazil Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 – 2028 (USD Million)
9.5.7 Mexico
9.5.7.1 Mexico Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 – 2028 (USD Million)
9.6 Middle East & Africa (Mea)
9.6.1 Mea Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Product & Services, 2017 – 2028 (USD Million)
9.6.2 Mea Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Type, 2017 – 2028 (USD Million)
9.6.3 Mea Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Source Of Isolation, 2017 – 2028 (USD Million)
9.6.4 Mea Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Indication, 2017 – 2028 (USD Million)
9.6.5 Mea Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Application, 2017 – 2028 (USD Million)
9.6.6 South Africa
9.6.6.1 South Africa Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 – 2028 (USD Million)
9.6.7 Saudi Arabia
9.6.7.1 Saudi Arabia Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 – 2028 (USD Million)
Chapter 10 Company Profile
10.1 Strategy Framework
10.2 Market Participation Categorization
10.3 Company Profiles
10.3.1 THERMO FISHER SCIENTIFIC
10.3.1.1 Company Overview
10.3.1.2 Financial Performance
10.3.1.3 Product Benchmarking
10.3.1.4 Strategic Initiatives
10.3.2 CELL APPLICATIONS, INC.
10.3.2.1 Company Overview
10.3.2.2 Financial Performance
10.3.2.3 Product Benchmarking
10.3.2.4 Strategic Initiatives
10.3.3 CYAGEN BIOSCIENCES INC.
10.3.3.1 Company Overview
10.3.3.2 Financial Performance
10.3.3.3 Product Benchmarking
10.3.4 AXOL BIOSCIENCES LTD.
10.3.4.1 Company Overview
10.3.4.2 Financial Performance
10.3.4.3 Product Benchmarking
10.3.4.4 Strategic Initiatives
10.3.5 CYTORI THERAPEUTICS INC
10.3.5.1 Company Overview
10.3.5.2 Financial Performance
10.3.5.3 Product Benchmarking
10.3.5.4 Strategic Initiatives
10.3.6 STEMCELL TECHNOLOGIES INC.
10.3.6.1 Company Overview
10.3.6.2 Financial Performance
10.3.6.3 Product Benchmarking
10.3.6.4 Strategic Initiatives
10.3.7 CELPROGEN INC.
10.3.7.1 Company Overview
10.3.7.2 Financial Performance
10.3.7.3 Product Benchmarking
10.3.7.4 Strategic Initiatives
10.3.8 BRAINSTORM CELL THERAPEUTICS INC.
10.3.8.1 Company Overview
10.3.8.2 Financial Performance
10.3.8.3 Product Benchmarking
10.3.8.4 Strategic Initiatives
10.3.9 STEMEDICA CELL TECHNOLOGIES INC.
10.3.9.1 Company Overview
10.3.9.2 Financial Performance
10.3.9.3 Product Benchmarking
10.3.9.4 Strategic Initiatives
10.3.10 MERCK KGAA (MILLIPORESIGMA)
10.3.10.1 Company Overview
10.3.10.2 Financial Performance
10.3.10.3 Product Benchmarking
10.3.10.4 Strategic Initiatives
10.3.11 SMITH+NEPHEW
10.3.11.1 Company Overview
10.3.11.2 Osiris Therapeutics Inc.
10.3.11.3 Financial Performance
10.3.11.4 Product Benchmarking
10.3.11.5 Strategic Initiatives
10.3.12 LONZA AG
10.3.12.1 Company Overview
10.3.12.2 Financial Performance
10.3.12.3 Product Benchmarking
10.3.13 PROMOCELL GMBH
10.3.13.1 Company Overview
10.3.13.2 Financial Performance
10.3.13.3 Product Benchmarking
10.3.13.4 Strategic Initiatives
10.3.14 SCIENCELL RESEARCH LABORATORIES
10.3.14.1 Company Overview
10.3.14.2 Financial Performance
10.3.14.3 Product Benchmarking
10.3.15 AMERICAN TYPE CULTURE COLLECTION
10.3.15.1 Company Overview
10.3.15.2 Financial Performance
10.3.15.3 Product Benchmarking

List of Tables

Table 1 List of secondary sources
Table 2 Comparison between the large-scale bioprocessing strategies for mesenchymal stem cells
Table 3 Approved MSC based products (as of 2020)
Table 4 Approved MSC based products (as of 2020)
Table 5 Examples of commercially available bone marrow derived MSCs and related products
Table 6 Completed and ongoing trials of MSCs in heart disease
Table 7 Recently started or planned clinical trials (As of September 2019)
Table 8 Clinical studies using MSC-based therapies for cancer treatment
Table 9 North America mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
Table 10 North America mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
Table 11 North America mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
Table 12 North America mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
Table 13 North America mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)
Table 14 U.S. mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
Table 15 U.S. mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
Table 16 U.S. mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
Table 17 U.S. mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
Table 18 U.S. mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)
Table 19 Canada mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
Table 20 Canada mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
Table 21 Canada mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
Table 22 Canada mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
Table 23 Canada mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)
Table 24 Europe mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
Table 25 Europe mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
Table 26 Europe mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
Table 27 Europe mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
Table 28 Europe mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)
Table 29 U.K. mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
Table 30 U.K. mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
Table 31 U.K. mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
Table 32 U.K. mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
Table 33 U.K. mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)
Table 34 Germany mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
Table 35 Germany mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
Table 36 Germany mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
Table 37 Germany mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
Table 38 Germany mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)
Table 39 France mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
Table 40 France mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
Table 41 France mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
Table 42 France mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
Table 43 France mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)
Table 44 Italy mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
Table 45 Italy mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
Table 46 Italy mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
Table 47 Italy mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
Table 48 Italy mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)
Table 49 Asia Pacific mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
Table 50 Asia Pacific mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
Table 51 Asia Pacific mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
Table 52 Asia Pacific mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
Table 53 Asia Pacific mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)
Table 54 China mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
Table 55 China mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
Table 56 China mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
Table 57 China mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
Table 58 China mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)
Table 59 Japan mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
Table 60 Japan mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
Table 61 Japan mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
Table 62 Japan mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
Table 63 Japan mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)
Table 64 India mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
Table 65 India mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
Table 66 India mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
Table 67 India mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
Table 68 India mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)
Table 69 South Korea mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
Table 70 South Korea mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
Table 71 South Korea mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
Table 72 South Korea mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
Table 73 South Korea mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)
Table 74 Latin America mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
Table 75 Latin America mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
Table 76 Latin America mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
Table 77 Latin America mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
Table 78 Latin America mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)
Table 79 Brazil mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
Table 80 Brazil mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
Table 81 Brazil mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
Table 82 Brazil mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
Table 83 Brazil mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)
Table 84 Mexico mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
Table 85 Mexico mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
Table 86 Mexico mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
Table 87 Mexico mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
Table 88 Mexico mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)
Table 89 Middle East & Africa mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
Table 90 Middle East & Africa mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
Table 91 Middle East & Africa mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
Table 92 Middle East & Africa mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
Table 93 Middle East & Africa mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)
Table 94 South Africa mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
Table 95 South Africa mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
Table 96 South Africa mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
Table 97 South Africa mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
Table 98 South Africa mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)
Table 99 Saudi Arabia mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
Table 100 Saudi Arabia mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
Table 101 Saudi Arabia mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
Table 102 Saudi Arabia mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
Table 103 Saudi Arabia mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Stem cell market pyramid
Fig. 9 Market trends & outlook
Fig. 10 Mesenchymal Stem Cells (MSCs) market driver impact
Fig. 11 Market restraint impact
Fig. 12 Penetration & growth prospect mapping for products, 2020
Fig. 13 SWOT analysis, by factor (Political & legal, economic, and technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Mesenchymal Stem Cells (MSCs) market: Product & services outlook and key takeaways
Fig. 16 Mesenchymal Stem Cells (MSCs) market: Product & services movement analysis
Fig. 17 Mesenchymal stem cell sourcing and isolation market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 18 Mesenchymal stem cell culture & cryopreservation market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 19 Mesenchymal stem cell differentiation market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 20 Mesenchymal stem cell characterization market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 21 Mesenchymal stem cells and cell lines market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 22 Mesenchymal stem cell kits, media & reagents market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 23 Other mesenchymal stem cell products market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 24 Mesenchymal stem cell services market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 25 Mesenchymal stem cells (MSCs) market: Type outlook and key takeaways
Fig. 26 Mesenchymal stem cells (MSCs) market: Type movement analysis
Fig. 27 Autologous MSCs market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 28 Allogeneic MSCs market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 29 Mesenchymal stem cells (MSCs) market: Source of isolation outlook and key takeaways
Fig. 30 Mesenchymal stem cells (MSCs) market: Source of isolation movement analysis
Fig. 31 Bone marrow derived MSCs market estimates and forecast, 2017 - 2028 (USD billion)
Fig. 32 Bone marrow derived MSCs market estimates and forecast, 2017 - 2028 (USD billion)
Fig. 33 Adipose tissue derived MSCs market estimates and forecast, 2017 - 2028 (USD billion)
Fig. 34 Other sources derived MSCs market estimates and forecast, 2017 - 2028 (USD billion)
Fig. 35 Mesenchymal stem cells (MSCs) market: Indication outlook and key takeaways
Fig. 36 Mesenchymal stem cells (MSCs) market: Indication movement analysis
Fig. 37 MSCs market estimates and forecast for bone & cartilage repair, 2017 - 2028 (USD Million)
Fig. 38 MSCs market estimates and forecast for cardiovascular diseases, 2017 - 2028 (USD Million)
Fig. 39 MSCs market estimates and forecast for inflammatory and immunological diseases, 2017 - 2028 (USD Million)
Fig. 40 MSCs market estimates and forecast for liver diseases, 2017 - 2028 (USD Million)
Fig. 41 MSCs market estimates and forecast for cancers, 2017 - 2028 (USD Million)
Fig. 42 MSCs market estimates and forecast for GvHD, 2017 - 2028 (USD Million)
Fig. 43 MSCs market estimates and forecast for others, 2017 - 2028 (USD Million)
Fig. 44 Mesenchymal Stem Cells (MSCs) market: Application outlook and key takeaways
Fig. 45 Mesenchymal Stem Cells (MSCs) market: Application movement analysis
Fig. 46 MSCs market estimates and forecast for disease modeling, 2017 - 2028 (USD Million)
Fig. 47 MSCs market estimates and forecast for drug development & discovery, 2017 - 2028 (USD Million)
Fig. 48 MSCs market estimates and forecast for stem cell banking, 2017 - 2028 (USD Million)
Fig. 49 MSCs market estimates and forecast for tissue engineering, 2017 - 2028 (USD Million)
Fig. 50 MSCs market estimates and forecast for toxicology studies, 2017 - 2028 (USD Million)
Fig. 51 MSCs market estimates and forecast for Others, 2017 - 2028 (USD Million)
Fig. 52 Mesenchymal stem cells (MSCs) market: Regional outlook and key takeaways
Fig. 53 Mesenchymal stem cells (MSCs) market: Regional movement analysis
Fig. 54 North America mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 55 U.S. mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 56 Canada mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 57 Europe mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 58 U.K. mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 59 Germany mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 60 France mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 61 Italy mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 62 Asia Pacific mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 63 China mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 64 Japan mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 65 India mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 66 South Korea mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 67 Latin America mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 68 Brazil mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 69 Mexico mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 70 Middle East & Africa mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 71 South Africa mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 72 Saudi Arabia mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 73 Strategy framework
Fig. 74 Market participation categorization

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の間葉系幹細胞市場2021-2028:製品&サービス別、種類別、分離源別(骨髄、臍帯血)、疾患別、用途別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆